These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial. JAMA; 1995 Jan; 273(3):199-208. PubMed ID: 7807658 [TBL] [Abstract][Full Text] [Related]
7. Differential associations of oral estradiol and conjugated equine estrogen with hemostatic biomarkers. Blondon M; van Hylckama Vlieg A; Wiggins KL; Harrington LB; McKnight B; Rice KM; Rosendaal FR; Heckbert SR; Psaty BM; Smith NL J Thromb Haemost; 2014 Jun; 12(6):879-86. PubMed ID: 24628832 [TBL] [Abstract][Full Text] [Related]
8. Changes in coagulation factors and fibrinolytic components of postmenopausal women receiving continuous hormone replacement therapy. Nozaki M; Ogata R; Koera K; Hashimoto K; Nakano H Climacteric; 1999 Jun; 2(2):124-30. PubMed ID: 11910665 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the antioxidant effects of equine estrogens, red wine components, vitamin E, and probucol on low-density lipoprotein oxidation in postmenopausal women. Bhavnani BR; Cecutti A; Gerulath A; Woolever AC; Berco M Menopause; 2018 Nov; 25(11):1214-1223. PubMed ID: 30358716 [TBL] [Abstract][Full Text] [Related]
10. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women. Vehkavaara S; Silveira A; Hakala-Ala-Pietilä T; Virkamäki A; Hovatta O; Hamsten A; Taskinen MR; Yki-Järvinen H Thromb Haemost; 2001 Apr; 85(4):619-25. PubMed ID: 11341495 [TBL] [Abstract][Full Text] [Related]
11. Effects of conjugated equine estrogens or raloxifene on lipid profile, coagulation and fibrinolysis factors in postmenopausal women. Dias AR; Melo RN; Gebara OC; D'Amico EA; Nussbacher A; Halbe HW; Pinotti JA Climacteric; 2005 Mar; 8(1):63-70. PubMed ID: 15804733 [TBL] [Abstract][Full Text] [Related]
12. Influence of hormone replacement therapy (17 beta-OH estradiol and medroxyprogesterone acetate) on plasma concentration of prothrombin fragment F1+2 and thrombin-antithrombin III complex in postmenopausal woman. Ciepłluch R; Czestochowska E Acta Haematol Pol; 1996; 27(1):21-5. PubMed ID: 8629439 [TBL] [Abstract][Full Text] [Related]
13. Effect of hormone replacement therapy, tibolone and raloxifene on serum lipids, apolipoprotein A1, apolipoprotein B and lipoprotein(a) in Greek postmenopausal women. Christodoulakos GE; Lambrinoudaki IV; Panoulis CP; Papadias CA; Kouskouni EE; Creatsas GC Gynecol Endocrinol; 2004 May; 18(5):244-57. PubMed ID: 15346660 [TBL] [Abstract][Full Text] [Related]
14. Effects of four different regimens of hormone replacement therapy on hemostatic parameters: a prospective randomized study. Taner MZ; Ozpolat E; Taskiran C; Onan MA; Gursel T; Karabulut E; Gursoy R; Himmetoglu O Maturitas; 2006 Feb; 53(3):267-73. PubMed ID: 15978753 [TBL] [Abstract][Full Text] [Related]
15. Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women. Koh KK; Mincemoyer R; Bui MN; Csako G; Pucino F; Guetta V; Waclawiw M; Cannon RO N Engl J Med; 1997 Mar; 336(10):683-90. PubMed ID: 9041098 [TBL] [Abstract][Full Text] [Related]
16. Effect of transdermal estradiol and oral conjugated estrogen on C-reactive protein in retinoid-placebo trial in healthy women. Decensi A; Omodei U; Robertson C; Bonanni B; Guerrieri-Gonzaga A; Ramazzotto F; Johansson H; Mora S; Sandri MT; Cazzaniga M; Franchi M; Pecorelli S Circulation; 2002 Sep; 106(10):1224-8. PubMed ID: 12208797 [TBL] [Abstract][Full Text] [Related]
17. Different effects of oral conjugated equine estrogens and transdermal estrogen on undercarboxylated osteocalcin concentration in postmenopausal women. Yasui T; Uemura H; Tomita J; Umino Y; Yamada M; Kuwahara A; Matsuzaki T; Maegawa M; Miura M; Irahara M Menopause; 2006; 13(4):651-9. PubMed ID: 16837887 [TBL] [Abstract][Full Text] [Related]
18. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women. Zegura B; Guzic-Salobir B; Sebestjen M; Keber I Menopause; 2006; 13(4):643-50. PubMed ID: 16837886 [TBL] [Abstract][Full Text] [Related]
19. Hormone replacement therapy, C-reactive protein, and fibrinogen in healthy postmenopausal women. Yilmazer M; Fenkci V; Fenkci S; Sonmezer M; Aktepe O; Altindis M; Kurtay G Maturitas; 2003 Dec; 46(4):245-53. PubMed ID: 14625121 [TBL] [Abstract][Full Text] [Related]
20. Effects of low-dose oral and transdermal estrogen replacement therapy on hemostatic factors in healthy postmenopausal women: a randomized placebo-controlled study. Post MS; van der Mooren MJ; van Baal WM; Blankenstein MA; Merkus HM; Kroeks MV; Franke HR; Kenemans P; Stehouwer CD Am J Obstet Gynecol; 2003 Nov; 189(5):1221-7. PubMed ID: 14634544 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]